Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Spectrum Pharmaceuticals: Bears Beware, Fusilev Strength Points To Strong Second Quarter
Spectrum Pharmaceuticals: Bears Beware, Fusilev Strength Points To Strong Second Quarter
Spectrum Pharmaceuticals: Bears Beware, Fusilev Strength Points To Strong Second Quarter
Submitted by
admin
on July 15, 2012 - 12:25pm
Source:
Seeking Alpha
News Tags:
Fusilev
Spectrum Pharmaceuticals
colorectal cancer
colon cancer
Headline:
Spectrum Pharmaceuticals: Bears Beware, Fusilev Strength Points To Strong Second Quarter
Do Not Allow Advertisers to Use My Personal information
